Search

The COVID-19 pandemic brought to the surface the critical qualities of air – airflow, ventilation, particulates etc. – in relation to the well-being of people living in high-rise. Engineering and architectural research has burgeoned in response. However, in focusing on models of airflow, ventilation and particulates as discrete variables, engineering and architectural discourse fails to capture the diverse ways that air enters into and shapes the everyday lived experience of high-rise dwelling. Drawing on research in Sydney's Southwestern suburbs, we reveal high-rise as an assemblage that links apartment dwelling with air, via car-dependent suburbanisation, pollution and climate-change induced temperature extremes in the Anthropocene. In addition to viruses, air teems with carbon, insects, noise and pollutants, while viscerally mediating human encounters with fluctuating temperatures. Multiple relations between people, buildings and air unfold simultaneously, confounding attempts to account for air's elemental milieu through single variables like greenhouse gas or COVID-19. While embedded in relations of power, high-rise assemblages unleash vernacular adaptation that through low-tech and low-cost technologies work to connect suburban high-rise with evolving ecological systems. Recognising the pharmacological quality of air, as both 'poison' and 'cure', we contrast models of high-rise as encapsulated environments with resident (and other) experiments that orient high-rise to the elements, and the interlinked challenges of urban living in the Anthropocene. [ABSTRACT FROM AUTHOR]

OBJECTIVES: Limited research has assessed how virtual care (VC) affects cardiovascular disease (CVD) risk management, especially in community clinic settings. This study assessed change in community clinic patients' CVD risk management during the COVID-19 pandemic and CVD risk factor control among patients who had primarily in-person or primarily VC visits. STUDY DESIGN: Retrospective interrupted time-series analysis. METHODS: Data came from an electronic health record shared by 52 community clinics for index (March 1, 2019, to February 29, 2020) and follow-up (July 1, 2020, to February 28, 2022) periods. Analyses compared follow-up period changes in slope and level of population monthly means of 10-year reversible CVD risk score, blood pressure (BP), and hemoglobin A1c (HbA1c) among patients whose completed follow-up period visits were primarily in person vs primarily VC. Propensity score weighting minimized confounding. RESULTS: There were 10,028 in-person and 6593 VC patients in CVD risk analyses, 9874 in-person and 5390 VC patients in BP analyses, and 8221 in-person and 4937 VC patients in HbA1c analyses. The VC group was more commonly younger, female, White, and urban. Mean reversible CVD risk, mean systolic BP, and percentage of BP measurements that were 140/90 mm Hg or higher increased significantly from index to follow-up periods in both groups. Rate of change between these periods was the same for all outcomes in both groups, regardless of care modality. CONCLUSIONS: Among community clinic patients with CVD risk, receiving a majority of care in person vs a majority of care via VC was not significantly associated with longitudinal trends in reversible CVD risk score or key CVD risk factors. [ABSTRACT FROM AUTHOR]

After central business districts (CBD) emptied from COVID-19 pandemic lockdowns and widespread working-from-home, culture and creativity feature prominently within recovery strategies, enrolling the arts and events to enliven urban precincts and attract people back into city centres. We draw upon resilience theory and creative city policymaking to critique present formulations of CBD revitalisation, and suggest alternatives. Despite overtures to social inclusion and environmental sustainability, revitalisation strategies mobilise pre-existing "vehicular ideas" that support corporate business interests in and claims on central city space. We articulate concerns around inclusivity, financial and property interests, creativity as consumption rather than production, livelihood concerns, and underwhelming acknowledgement of pandemic disruption. Instead of placing creativity in service of the competitive positioning of the CBD, we ask: what is the very purpose of the post-pandemic CBD, and who is the CBD for? Answering these questions invitesmore courageous propositions that seize once-in-a-generation opportunities for transformational change. [ABSTRACT FROM AUTHOR]

OBJECTIVES: Understanding how the COVID-19 pandemic affected cardiovascular disease (CVD) risk monitoring in primary care may inform new approaches for addressing modifiable CVD risks. This study examined how pandemic-driven changes in primary care delivery affected CVD risk management processes. STUDY DESIGN: This retrospective study used electronic health record data from patients at 70 primary care community clinics with scheduled appointments from September 1, 2018, to September 30, 2021. METHODS: Analyses examined associations between appointment type and select care process measures: appointment completion rates, time to appointment, and up-to-date documentation for blood pressure (BP) and hemoglobin A1c (HbA1c). RESULTS: Of 1,179,542 eligible scheduled primary care appointments, completion rates were higher for virtual care (VC) vs in-person appointments (10.7 percentage points [PP]; 95% CI, 10.5-11.0; P < .001). Time to appointment was shorter for VC vs in-person appointments (--3.9 days; 95% CI, --4.1 to --3.7; P < .001). BP documentation was higher for appointments completed pre-- vs post pandemic onset (16.2 PP; 95% CI, 16.0-16.5; P < .001) and for appointments completed in person vs VC (54.9 PP; 95% CI, 54.6-55.2; P < .001). HbA1c documentation was higher for completed appointments after pandemic onset vs before (5.9 PP; 95% CI, 5.1-6.7; P < .001) and for completed VC appointments vs in-person appointments (3.9 PP; 95% CI, 3.0-4.7; P < .001). CONCLUSIONS: After pandemic onset, appointment completion rates were higher, time to appointment was shorter, HbA1c documentation increased, and BP documentation decreased. Future research should explore the advantages of using VC for CVD risk management while continuing to monitor for unintended consequences. [ABSTRACT FROM AUTHOR]